Growth Metrics

Eli Lilly (LLY) Change in Acquisitions & Divestments (2016 - 2025)

Eli Lilly's Change in Acquisitions & Divestments history spans 17 years, with the latest figure at $132.0 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 135.71% year-over-year to $132.0 million; the TTM value through Dec 2025 reached $964.0 million, up 157.75%, while the annual FY2025 figure was $964.0 million, 157.75% up from the prior year.
  • Change in Acquisitions & Divestments reached $132.0 million in Q4 2025 per LLY's latest filing, down from $556.1 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $753.4 million in Q4 2021 to a low of -$85.4 million in Q3 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $149.4 million, with a median of $69.2 million recorded in 2024.
  • The largest YoY upside for Change in Acquisitions & Divestments was 719.65% in 2022 against a maximum downside of 437.55% in 2022.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $753.4 million in 2021, then crashed by 65.61% to $259.1 million in 2022, then plummeted by 87.73% to $31.8 million in 2023, then skyrocketed by 76.1% to $56.0 million in 2024, then skyrocketed by 135.71% to $132.0 million in 2025.
  • Per Business Quant, the three most recent readings for LLY's Change in Acquisitions & Divestments are $132.0 million (Q4 2025), $556.1 million (Q3 2025), and $204.3 million (Q2 2025).